Product Description
An inhibitor of Xanthine Oxidase which decreases uric acid production; also inhibits de novo pyrimidine biosynthesis.
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Specifications
SKU | 0219015025 |
Alternate Names | 1H-Pyrazolo(3,4-d)pyrimidin-4-ol; 4-Hydroxypyrazolo(3,4-d)pyrimidine; 4-Hydroxypyrazolo[3,4-d]pyrimidine; HPP |
Base Catalog Number | 19015025 |
Biochemical Physiological Actions | Inhibitor of xanthine oxidase and de novo pyrimidine biosynthesis. A classical agent in treatment of hyperuricemia and gout. |
CAS # | 315-30-0 |
EC Number | 206-250-9 |
Hazard Statements | H301-H317 |
Melting Point | >300 °C(Lit.) |
Molecular Formula | C5H4N4O |
Molecular Weight | 136.1 |
Pack Size | 25 g |
Personal Protective Equipment | Eyeshields, Faceshields, Gloves, respirator cartridges |
pKa | pKa = 10.2 (Lit.) |
RTECS Number | UR0785000 |
Safety Symbol | GHS06 |
Solubility | Soluble in 1 M sodium hydroxide (50 mg/mL), water (0.48 mg/mL), chloroform (0.60 mg/mL), ethanol (0.30 mg/mL), methanol, DMSO (4.6 mg/mL) and DMF (20 mg/mL- yields a slightly cloudy, colorless solution). |
Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |
UV Visible Absorbance | 247 - 252 nm (methanol) |
Documents
Datasheet
Datasheet